Search Results 1051-1060 of 17822 for monoclonal antibody

1. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

   Other monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, antibody-like drugs, cytokines, cell therapies, or radioimmunoconjugates: 4 weeks.

2. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or ...

3. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

   Severe infection or inflammation at the time of Screening. 2. History of clinically significant hypersensitivity associated with monoclonal antibody

4. Ulcerative colitis - Diagnosis and treatment - Mayo Clinic

   Monoclonal antibody risankizumab for ulcerative colitis. JAMA. 2024; doi:10.1001/jama.2024.8819. Managing flares and IBD symptoms. Crohn's and Colitis ...

5. A Study Of Long-acting Antibodies Alone And In Combinations For Moderate To Severe Ulcerative Colitis - Mayo Clinic

   This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...

6. A Study to Evaluate the Safety and Effectiveness of JBH492 in Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma - Mayo Clinic

   ... monoclonal antibody administration. Any prior history of treatment with maytansine (DM1 or DM4)-based ADC. Known intolerance to a maytansinoid. Patients ...

7. A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2) - Mayo Clinic

   antibody (TDB) antibody including non BCMA targeting TDB - Prior use of any monoclonal antibody (mAb), radioimmunoconjugate, or ADC as anti-cancer therapy ...

8. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

   ... antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. ... monoclonal antibody therapy (panitumumab or cetuximab) ...

9. Multiple myeloma: Its evolution, treatment and the quest to catch it early

   The earliest phase of monoclonal gammopathies is monoclonal ... When a person has MGUS, monoclonal ... antibody (anti-CD38) that targets a surface ...

10. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Prior antibody treatment for cancer must have been ... Sacituzumab govitecan-hziy is an antibody-drug conjugate that combines a humanized monoclonal ...